Meeting
2023 ASCO Genitourinary Cancers Symposium
Germline testing for men with prostate cancer: Need to broaden the indications in Europe?
Authors
Elena Trevisi
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Elena Trevisi , Kira-Lee Koster , Karl Heinimann , Ursina Zuerrer , Fabio Turco , Davide Giovanni Bosetti , Ilaria Colombo , Silvia Maitz , Marta Nerone , Aurelius Gabriel Omlin , Ursula Vogl , Silke Gillessen , Rossella Graffeo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 383)
DOI
10.1200/JCO.2023.41.6_suppl.383
Abstract #
383
Poster Bd #
N20
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Inherited pathologic mutations and family history in patients with prostate cancer.
First Author: Shuwen Lin
Poster
2020 Genitourinary Cancers Symposium
Integrating comprehensive genomic profiling into the clinical management of prostate cancer patients: A single institution community practice experience.
First Author: Neal D. Shore
Poster
2023 ASCO Annual Meeting
Prevalence of germline variants in patients with pancreatic neuroendocrine tumors.
First Author: Chirayu Mohindroo
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II study of rucaparib monotherapy in nonmetastatic, hormone-sensitive prostate cancer (nmHSPC) with “BCRAness” genotype (ROAR).
First Author: Kamal Kant Kant Sahu